Relapsed Myelodysplastic Syndromes
3 clinical trials · Condition
◉ Watch Relapsed Myelodysplastic Syndromes
| Record | Firm | Date |
|---|---|---|
| FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies (NCT04891757) | Foghorn Therapeutics Inc. | 2021-06-14 |
| Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) (NCT03091933) | Ciusss de L'Est de l'Île de Montréal | 2017-02-06 |
Track Relapsed Myelodysplastic Syndromes automatically
Every clearance here is in the API, with alerts when new ones post.